產品詳情
簡單介紹：
Anti-Nebraska Calf Diarrhea Virus NSP4抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-Nebraska Calf Diarrhea Virus NSP4抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-Nebraska Calf Diarrhea Virus NSP4
Cat. Number:
Anti-Nebraska Calf Diarrhea Virus NSP4抗體KL-19094R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Bovine virus diarrhea (BVD) is a complicated disease to discuss as it can result in a wide variety of disease problems from very mild to very severe. BVD can be one of the most devastating diseases cattle encounter and one of theAnti-Nebraska Calf Diarrhea Virus NSP4抗體 hardest to get rid of when it attacks a herd. The viruses that cause BVD have been grouped into two genotypes, Type I and Type II. The disease syndrome caused by the two genotypes is basically the same, however disease caused by Type II infection is often more severe. The various disease syndromes noted in cattle infected with BVD virus are mainly attributed to the age of the animal when it became infected and to certain characteristics of the virus involved.
Also known as:
Non-structural glycoprotein 4;Anti-Nebraska Calf Diarrhea Virus NSP4抗體 NSP4; NSP4_ROTBN; NCVP5; NS28.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Bovine(Nebraska Anti-Nebraska Calf Diarrhea Virus NSP4抗體Calf Diarrhea Virus).
●
Immunogen: KLH conjugated synthetic peptide derived from human Nebraska Calf Diarrhea Virus.
●
Predicted Molecular Weight: 20kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 Anti-Nebraska Calf Diarrhea Virus NSP4抗體
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
